Alphabet, Thermo Fisher Scientific, and Hims & Hers Health are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies operating in the medical and health-related industries—ranging from pharmaceutical and biotechnology firms to medical device manufacturers, hospitals, and insurers. They give investors exposure to the healthcare sector’s performance, which is driven by factors such as regulatory approvals, demographic trends, technological innovation, and policy changes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
Alphabet (GOOGL)
Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube.
Shares of NASDAQ:GOOGL traded down $1.06 during mid-day trading on Wednesday, reaching $190.29. 25,158,424 shares of the stock were exchanged, compared to its average volume of 32,292,724. Alphabet has a one year low of $140.53 and a one year high of $207.05. The company has a market cap of $2.31 trillion, a P/E ratio of 21.20, a P/E/G ratio of 1.33 and a beta of 1.00. The stock's 50 day simple moving average is $172.90 and its 200-day simple moving average is $172.89. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.03.
Read Our Latest Research Report on GOOGL
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of NYSE TMO traded up $48.60 during mid-day trading on Wednesday, hitting $476.22. 5,801,643 shares of the stock traded hands, compared to its average volume of 2,051,617. The company has a market cap of $179.77 billion, a PE ratio of 27.92, a price-to-earnings-growth ratio of 1.96 and a beta of 0.77. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38. The firm has a 50 day simple moving average of $410.38 and a two-hundred day simple moving average of $472.32. Thermo Fisher Scientific has a twelve month low of $385.46 and a twelve month high of $627.88.
Read Our Latest Research Report on TMO
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS traded up $6.64 during trading on Wednesday, reaching $56.65. The stock had a trading volume of 48,497,137 shares, compared to its average volume of 24,388,766. The business has a 50-day moving average of $53.82 and a 200-day moving average of $42.04. Hims & Hers Health has a one year low of $13.47 and a one year high of $72.98. The stock has a market cap of $12.68 billion, a PE ratio of 81.27, a PEG ratio of 1.76 and a beta of 2.02.
Read Our Latest Research Report on HIMS
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Alphabet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphabet wasn't on the list.
While Alphabet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
